Stéphane De Lombaert

1.6k citations

49 papers · 1.2k indexed · h-index 22

Co-authors: Arco Y. Jeng Angelo J. Trapani Louis Blanchard Léon Ghosez Jenny Tan Alison Kukulka Neil A. Farrow Yumi Sakane
Topics: Nitric Oxide and Endothelin Effects (13 papers)Peptidase Inhibition and Analysis (9 papers)Neuropeptides and Animal Physiology (7 papers)
Cited by: Organic Chemistry Biochemistry Biological Psychiatry
Journals: Journal of the American Chemical Society Journal of Medicinal Chemistry Journal of Pharmacology and Experimental Therapeutics
Partner nations: United States Switzerland France

In The Last Decade

Stéphane De Lombaert

49 papers receiving 1.1k citations

Peers

Countries citing papers authored by Stéphane De Lombaert

Since Specialization

Citations

This map shows the geographic impact of Stéphane De Lombaert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stéphane De Lombaert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stéphane De Lombaert more than expected).

Fields of papers citing papers by Stéphane De Lombaert

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stéphane De Lombaert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stéphane De Lombaert. The network helps show where Stéphane De Lombaert may publish in the future.

Co-authorship network of co-authors of Stéphane De Lombaert

This figure shows the co-authorship network connecting the top 25 collaborators of Stéphane De Lombaert. A scholar is included among the top collaborators of Stéphane De Lombaert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stéphane De Lombaert. Stéphane De Lombaert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Optimization of spirocyclic proline tryptophan hydroxylase-1 inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Daniel R. Goldberg,Stéphane De Lombaert,Robert J. Aiello,(unknown),Nicole Barucci,Qing Zhang,Vishwas Paralkar,Adam J. Stein,Melissa C. Holt,(unknown),William J. Zavadoski	29
2	Discovery of acyl guanidine tryptophan hydroxylase-1 inhibitors 2016 ·Bioorganic & Medicinal Chemistry Letters ·Daniel R. Goldberg,Stéphane De Lombaert,Robert J. Aiello,(unknown),Nicole Barucci,Qing Zhang,Vishwas Paralkar,Adam J. Stein,(unknown),William J. Zavadoski	11
3	Discovery of Potent, Selective Chymase Inhibitors via Fragment Linking Strategies 2013 ·Journal of Medicinal Chemistry ·Steven J. Taylor,Anil K. Padyana,(unknown),Shuang Liang,Ming‐Hong Hao,Stéphane De Lombaert,John Proudfoot,Bennett Farmer,Xiang Li,(unknown),Leslie Martin,(unknown),(unknown),Steven S. Pullen,Hidenori Takahashi	23
4	Benzimidazolone as potent chymase inhibitor: Modulation of reactive metabolite formation in the hydrophobic (P1) region 2011 ·Bioorganic & Medicinal Chemistry Letters ·(unknown),(unknown),Jin‐Man Kim,Ming‐Hong Hao,Kevin Qian,Neil A. Farrow,(unknown),(unknown),Richard D. Schneiderman,Elias August,Leslie Martin,(unknown),Steven S. Pullen,Hidenori Takahashi,Stéphane De Lombaert	16
5	Design and synthesis of substituted nicotinamides as inhibitors of soluble epoxide hydrolase 2009 ·Bioorganic & Medicinal Chemistry Letters ·Steven J. Taylor,(unknown),Anne B. Eldrup,Neil A. Farrow,Ingo Muegge,Alison Kukulka,Alisa K. Kabcenell,Stéphane De Lombaert	16
6	Optimization of piperidyl-ureas as inhibitors of soluble epoxide hydrolase 2009 ·Bioorganic & Medicinal Chemistry Letters ·Anne B. Eldrup,(unknown),Neil A. Farrow,Alison Kukulka,Stéphane De Lombaert	32
7	Aminoquinazolines as TRPV1 antagonists: Modulation of drug-like properties through the exploration of 2-position substitution 2008 ·Bioorganic & Medicinal Chemistry Letters ·Charles A. Blum,Xiaozhang Zheng,Harry L. Brielmann,Kevin J. Hodgetts,Rajagopal Bakthavatchalam,Jayaraman Chandrasekhar,James E. Krause,Daniel N. Cortright,David J. Matson,Marci Crandall,(unknown),Lawrence K. Fung,(unknown),Mark T. Kershaw,Stéphane De Lombaert,Bertrand L. Chenard	13
8	Discovery of potent inhibitors of interleukin-2 inducible T-cell kinase (ITK) through structure-based drug design 2008 ·Bioorganic & Medicinal Chemistry Letters ·Brian N. Cook,Jörg Bentzien,André White,(unknown),Ji Wang,(unknown),(unknown),(unknown),Mohammed A. Kashem,Stanley Kugler,John P. Wolak,Gregory P. Roth,Stéphane De Lombaert,Steven S. Pullen,Hidenori Takahashi	29
9	2-Arylpyrimidines: Novel CRF-1 receptor antagonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·Tae‐young Yoon,Stéphane De Lombaert,Robbin Brodbeck,Michael Gulianello,James E. Krause,Alan Hutchison,(unknown),Ping Ge,John H. Kehne,Diane C. Hoffman,Jayaraman Chandrasekhar,Darı́o Doller,Kevin J. Hodgetts	8
10	2-Aryl-3,6-dialkyl-5-dialkylaminopyrimidin-4-ones as novel crf-1 receptor antagonists 2003 ·Bioorganic & Medicinal Chemistry Letters ·Kevin J. Hodgetts,Tae‐young Yoon,Jianhua Huang,Michael Gulianello,(unknown),Renee Primus,Robbin Brodbeck,Stéphane De Lombaert,Darı́o Doller	14
11	3-Aryl pyrazolo[4,3-d]pyrimidine derivatives 2002 ·Bioorganic & Medicinal Chemistry Letters ·Jun Yuan,Michael Gulianello,Stéphane De Lombaert,Robbin Brodbeck,(unknown),Kevin J. Hodgetts	30
12	Cgs 34043 2000 ·Life Sciences ·Angelo J. Trapani,Stéphane De Lombaert,Michael E. Beil,Charles W. Bruseo,Paula Savage,Mary Chou,Arco Y. Jeng	10
13	Design and Synthesis of a Potent and Selective Endothelin-Converting Enzyme Inhibitor, CGS 35066 2000 ·Journal of Cardiovascular Pharmacology ·Arco Y. Jeng,Stéphane De Lombaert,Michael E. Beil,Charles W. Bruseo,Paula Savage,Mary Chou,Angelo J. Trapani	19
14	Pharmacological Properties of CGS 35066, a Potent and Selective Endothelin-Converting Enzyme Inhibitor, in Conscious Rats 2000 ·Journal of Cardiovascular Pharmacology ·Angelo J. Trapani,Michael E. Beil,Charles W. Bruseo,Stéphane De Lombaert,Arco Y. Jeng	17
15	Differential Inhibition of Wild-Type Endothelin-Converting Enzyme-1 and Its Mutants 1998 ·Journal of Cardiovascular Pharmacology ·Paula Savage,Stéphane De Lombaert,Kohei Shimada,Kazuhiko Tanzawa,Arco Y. Jeng	2
16	Antihypertensive and Natriuretic Effects of CGS 30440, a Dual Inhibitor of Angiotensin-Converting Enzyme and Neutral Endopeptidase 24.11 1998 ·Journal of Pharmacology and Experimental Therapeutics ·(unknown),(unknown),Angelo J. Trapani,(unknown),(unknown),Stéphane De Lombaert,Rodney W. Lappe,Cynthia A. Fink	18
17	Potent non-peptidic dual inhibitors of endothelin-converting enzyme and neutral endopeptidase 24.11 1997 ·Bioorganic & Medicinal Chemistry Letters ·Stéphane De Lombaert,(unknown),Louis Blanchard,Jenny Tan,Daniël Hoyer,(unknown),(unknown),Eli M. Wallace,(unknown),Paula Savage,Arco Y. Jeng	26
18	Design and Pharmacology of Dual Angiotensin-Converting Enzyme and Neutral Endopeptidase Inhibitors 1996 ·Current Pharmaceutical Design ·Stéphane De Lombaert,(unknown),Cynthia A. Fink,Angelo J. Trapani	9
19	Inhibition of Big ET-1-Induced Pressor Response by an Orally Active Dual Inhibitor of Endothelin-Converting Enzyme and Neutral Endopeptidase 24.11 1995 ·Journal of Cardiovascular Pharmacology ·Angelo J. Trapani,Stéphane De Lombaert,(unknown),Arco Y. Jeng	20
20	N-Phosphonomethyl Dipeptides and Their Phosphonate Prodrugs, a New Generation of Neutral Endopeptidase (NEP, EC 3.4.24.11) Inhibitors 1994 ·Journal of Medicinal Chemistry ·Stéphane De Lombaert,Mark D. Erion,Jenny Tan,Louis Blanchard,(unknown),Rajesh Ghai,Yumi Sakane,Carol Berry,Angelo J. Trapani	69

About Stéphane De Lombaert

Stéphane De Lombaert is a scholar working on Behavioral Neuroscience, Biological Psychiatry and Cellular and Molecular Neuroscience, having authored 49 papers that have together received 1.2k indexed citations. Recurring topics across this work include Nitric Oxide and Endothelin Effects (13 papers), Peptidase Inhibition and Analysis (9 papers) and Neuropeptides and Animal Physiology (7 papers). The work is most often cited by research in Organic Chemistry (599 citations), Biochemistry (140 citations) and Biological Psychiatry (21 citations). Stéphane De Lombaert has collaborated with scholars based in United States, Switzerland and France. Frequent co-authors include Arco Y. Jeng, Angelo J. Trapani, Louis Blanchard, Léon Ghosez, Jenny Tan, Alison Kukulka, Neil A. Farrow, Yumi Sakane, Anne B. Eldrup and Carol Berry. Their work appears in journals such as Journal of the American Chemical Society, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact